Other studies demonstrated that HIF-2α appears to be an attractive target because it is specifically expressed by brain tumor stem cells but not neural progenitor cells, whereas HIF-1α is up-regulated in these cellular populations [57]. Here, HIF1A is linked to brain neoplasm.